Blockade of the renin-angiotensin system (RAS) using angiotensin-converting enzyme inhibitors (ACEi) or angiotensin II receptor blockers (ARB) is superior to using other anti-hypertensive agents in DN. This evidence concerns the gene ACE and liver dysplastic nodule.